CASI PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
CASI PHARMACEUTICALS, INC. (CASIF) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 617.28 thousand shares for the 12-month period ending 2023-12-31, per its 20-F filed 2025-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2025-03-31
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month |
|---|---|
| 2023-12-31 | 617.28K shares 20-F · filed 2025-03-31 |
| 2022-12-31 | 209.89K shares 20-F · filed 2023-04-26 |
| 2021-12-31 | 209.89K shares 20-F · filed 2024-03-28 |
| 2020-12-31 | 148.97K shares 20-F · filed 2023-04-26 |